A patient support organization for people with GIST (gastrointestinal stromal tumour), and their families & friends.
Canada
Joined March 2013
- Tweets106
- Following34
- Followers124
- Likes17
Join us at our first #GIST Learn Online event on August 15, 2020. Find out more: liferaftgroup.ca/register-no…
Don't miss Virtual Life Fest 2020 featuring talks by a panel of #GIST experts including our own president, David Josephy. liferaftgroup.org/event/virt…
Don't forget to register to see the latest information being shared in our traditional GIST 101 presentation with Dr. David Josephy and through several panels featuring top GIST specialists and researchers plus a program targeted to the SDH community. liferaftgroup.org/event/virt…
Life Raft Group CAN retweeted
We are excited to announce Health Canada’s authorization of QINLOCK™ via the U.S. FDA’s Project Orbis initiative. We look forward to bringing this important new therapy to eligible patients in Canada. bit.ly/3hTP3gv
#Deciphera
Life Raft Group CAN retweeted
Senior Research Director Pete Knox has summarized key studies presented at ASCO. ow.ly/ysI450zVBXg
Don't miss this chance to learn more about your #gist pathology report withe Life Raft Group USA.
REMINDER: Join our webinar, "Gastrointestinal Stromal Tumors: How to Understand Your Pathology Report" on June 16th at 12-1pm. ow.ly/EgIL50zRkGa
Life Raft Group CAN retweeted
Today, we received @US_FDA approval for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor (#GIST) harboring a PDGFRA exon 18 mutation, including PDGFRA D842V mutations. Learn more: bit.ly/2R0aKyZ
Deciphera has introduced an expanded access program for their drug #ripretinib for #GIST. For more details, head to deciphera.com/pipeline/expan…
Life Raft Group CAN retweeted
$DCPH also presented data at #Targets19 from the Ph. 1 study of ripretinib & the Ph. 1 study of DCC-3014, an oral inhibitor of CSF1R, in patients with advanced solid tumors. Read more here: bit.ly/36fB9Q4
Don't miss this webinar about "Novel Treatments in GIST" by Dr. Jonathan Trent on July 24. #GIST
Save the date for this webinar with Dr. @JTrentMDPhD sponsored by @sarcomapatients liferaftgroup.org/event/nove…
Tune into Life Raft Group's (USA) webinar on side effect management on June 18th!
Save the date for our webinar on #SymptomandSideEffectManagementinGIST on June 18th. #GISTEducation #SurvivalSeries liferaftgroup.org/event/symp…
Check out the full agenda for the Vancouver GIST Day of Learning. Register now! buff.ly/2XKQALO
Life Raft Group CAN retweeted
Dr. Yu Wang and Jerry Call, members of the LRG Real World Evidence Team, have a study on #mutationaltesting in #GIST online: ncbi.nlm.nih.gov/pubmed/3091…
Life Raft Group CAN retweeted
LRG's #RealWorldEvidence Team including lead author Jerry Call, Dr. Yu Wang, Denisse Montoya and Norman Scherzer, along with Dr. Michael Heinrich of OHSU, have published a study on the impact of treatments beyond first line in #GIST on #Overallsurvival. clinicalsarcomaresearch.biom…
Life Raft Group CAN retweeted
Proud to be part of this #GISTResearch study, spearheaded by the #LRGResearch Team. clinicalsarcomaresearch.biom…
Join Life Raft Group Canada at our next regional meeting in Toronto on March 31st. There will be a round table discussion, presentation, and Q&A on #GIST. For more information and registration: buff.ly/2H6vXok
Dr. Michael Heinrich from the OHSU Knight Cancer Institute will be the keynote speaker at the #GIST Day of Learning in Vancouver on April 27th. Register for the event at buff.ly/2XKQALO
Make a $35 donation to GIST Sarcoma Life Raft Group Canada and receive a GIST Busters T-shirt as as gift! liferaftgroup.ca/fundraiser/ #GIST #Sarcoma #Cancer #Donate
GIST Day of Learning coming to Halifax (May 26) and Fredericton (May 27) more info on our website liferaftgroup.ca/gist-day-of… #GDOL #maritimes #gistcancer #raredisease
